These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38333356)

  • 21. [Ebola : an uncontrolled outbreak despite vaccines and new treatments].
    Vetter P; Kaiser L
    Rev Med Suisse; 2020 Apr; 16(690):739-743. PubMed ID: 32301308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons Learned from Reinforcing Epidemiologic Surveillance During the 2017 Ebola Outbreak in the Likati District, Democratic Republic of the Congo.
    Hemingway-Foday JJ; Ngoyi BF; Tunda C; Stolka KB; Grimes KEL; Lubula L; Mossoko M; Kebela BI; Brown LM; MacDonald PDM
    Health Secur; 2020 Jan; 18(S1):S81-S91. PubMed ID: 32004132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April-May, 2018: an epidemiological study.
    Ebola Outbreak Epidemiology Team
    Lancet; 2018 Jul; 392(10143):213-221. PubMed ID: 30047375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Being Pregnant during the Kivu Ebola Virus Outbreak in DR Congo: The rVSV-ZEBOV Vaccine and Its Accessibility by Mothers and Infants during Humanitarian Crises and in Conflict Areas.
    Schwartz DA
    Vaccines (Basel); 2020 Jan; 8(1):. PubMed ID: 31979026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ebola in the Eastern Democratic Republic of Congo: One Health approach to infectious disease control.
    Sikakulya FK; Mulisya O; Munyambalu DK; Bunduki GK
    One Health; 2020 Jun; 9():100117. PubMed ID: 31993475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burial workers' perceptions of community resistance and support systems during an Ebola outbreak in the Eastern Democratic Republic of the Congo: a qualitative study.
    Zwick H; Asobee MS; Mitton IK; Headley J; Eagle DE
    Confl Health; 2023 May; 17(1):25. PubMed ID: 37231435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection, health seeking, or a laissez-passer: Participants' decision-making in an EVD vaccine trial in the eastern Democratic Republic of the Congo.
    James M; Kasereka JG; Kasiwa B; Kavunga-Membo H; Kambale K; Grais R; Muyembe-Tamfum JJ; Bausch DG; Watson-Jones D; Lees S
    Soc Sci Med; 2023 Apr; 323():115833. PubMed ID: 36934528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceptions on the collection of body fluids for research on persistence of Ebola virus: A qualitative study.
    Kutalek R; Baingana F; Sevalie S; Broutet N; Thorson A
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008327. PubMed ID: 32407312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 2018/19 Ebola epidemic the Democratic Republic of the Congo (DRC): epidemiology, outbreak control, and conflict.
    Shears P; Garavan C
    Infect Prev Pract; 2020 Mar; 2(1):100038. PubMed ID: 34368690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life and factors associated among caregivers of adolescent and young adult Ebola survivors in Democratic Republic of the Congo, a cross-sectional study.
    Munyumu K; Wafula C; Were V; Katungu F; Mbasa N; Kaseje M
    BMC Public Health; 2023 Nov; 23(1):2362. PubMed ID: 38031082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Projections of epidemic transmission and estimation of vaccination impact during an ongoing Ebola virus disease outbreak in Northeastern Democratic Republic of Congo, as of Feb. 25, 2019.
    Worden L; Wannier R; Hoff NA; Musene K; Selo B; Mossoko M; Okitolonda-Wemakoy E; Muyembe Tamfum JJ; Rutherford GW; Lietman TM; Rimoin AW; Porco TC; Kelly JD
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007512. PubMed ID: 31381606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence.
    Islam MS; Kamal AM; Kabir A; Southern DL; Khan SH; Hasan SMM; Sarkar T; Sharmin S; Das S; Roy T; Harun MGD; Chughtai AA; Homaira N; Seale H
    PLoS One; 2021; 16(5):e0251605. PubMed ID: 33979412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo.
    Hoff NA; Bratcher A; Mukadi P; Ahuka S; Kabamba M; Musene K; Halbrook M; Dzogong C; Mwamba GN; Mbala P; Kelly JD; Kompany JP; Tambu M; Kaba D; Kebela-Ilunga B; Muyemebe-Tamfum JJ; Rimoin AW
    Vaccine; 2021 Dec; 39(51):7464-7469. PubMed ID: 34799143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of the Ebola Virus Disease Epidemic among Women in the Provinces of North Kivu and Ituri in the Democratic Republic of the Congo.
    Onyeneho NG; Aronu NI; Igwe I; Okeibunor J; Diarra T; Anoko JN; Djingarey MH; Yoti Z; Chamla D; Gueye AS
    J Immunol Sci; 2023 May; Suppl 3():11-19. PubMed ID: 38333354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustainable strategies for Ebola virus disease outbreak preparedness in Africa: a case study on lessons learnt in countries neighbouring the Democratic Republic of the Congo.
    Ryan CS; Belizaire MD; Nanyunja M; Olu OO; Ahmed YA; Latt A; Kol MT; Bamuleke B; Tusiime J; Nsabimbona N; Conteh I; Nyashanu S; Ramadan PO; Woldetsadik SF; Nkata JM; Ntwari JT; Nzeyimana SD; Ouedraogo L; Batona G; Ndahindwa V; Mgamb EA; Armah M; Wamala JF; Guyo AG; Freeman AYS; Chimbaru A; Komakech I; Kuku M; Firmino WM; Saguti GE; Msemwa F; O-Tipo S; Kalubula PC; Nsenga N; Talisuna AO
    Infect Dis Poverty; 2022 Dec; 11(1):118. PubMed ID: 36461100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Being a midwife is being prepared to help women in very difficult conditions': midwives' experiences of working in the rural and fragile settings of Ituri Province, Democratic Republic of Congo.
    Baba A; Theobald S; Martineau T; Sabuni P; Nobabo MM; Alitimango A; Raven J
    Rural Remote Health; 2020 Jun; 20(2):5677. PubMed ID: 32531171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.
    Watson-Jones D; Kavunga-Membo H; Grais RF; Ahuka S; Roberts N; Edmunds WJ; Choi EM; Roberts CH; Edwards T; Camacho A; Lees S; Leyssen M; Spiessens B; Luhn K; Douoguih M; Hatchett R; Bausch DG; Muyembe JJ;
    BMJ Open; 2022 Mar; 12(3):e055596. PubMed ID: 35260458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Institutional trust and misinformation in the response to the 2018-19 Ebola outbreak in North Kivu, DR Congo: a population-based survey.
    Vinck P; Pham PN; Bindu KK; Bedford J; Nilles EJ
    Lancet Infect Dis; 2019 May; 19(5):529-536. PubMed ID: 30928435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of a safe and dignified burial intervention during an Ebola epidemic in the eastern Democratic Republic of the Congo, 2018-2019.
    Warsame A; Eamer G; Kai A; Dios LR; Rohan H; Keating P; Katshishi J; Checchi F
    BMC Med; 2023 Dec; 21(1):484. PubMed ID: 38049815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Itineraries during the Ebola Epidemic in the Democratic Republic of Congo.
    Diarra T; Okeibunor J; Diallo B; Onyeneho N; Rodrigue B; N'da Konan Yao M; Yoti Z; Fall S
    J Immunol Sci; 2023 May; Suppl 3():88-101. PubMed ID: 38333360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.